Positivity Rate, Predictors, and Outcome of Paediatric Lassa Fever Disease (LFD) in a Lassa Fever Endemic State,

Maria-Lauretta Orji1, Nnennaya Anthony Ajayi2, Nnamdi Benson Onyire1

  • 1Department of Paediatrics, Alex Ekwueme Federal University Teaching Hospital Abakaliki, Ebonyi State.

Insights

Paediatric Lassa fever disease (LFD) has a high positivity and case fatality rate in endemic areas. Early healthcare seeking for febrile illnesses in children is crucial.

Area of Science:

  • Pediatric Infectious Diseases
  • Epidemiology
  • Viral Hemorrhagic Fevers

Background:

  • Lassa fever disease (LFD) in children is poorly documented, especially regarding its pattern and case fatality rate.
  • Understanding LFD's impact on pediatric populations in endemic regions is critical for public health.
  • Limited data exists on the clinical presentation and outcomes of Lassa fever in children.

Purpose of the Study:

  • To determine the epidemiological pattern of pediatric Lassa fever disease.
  • To investigate the clinical outcomes and case fatality rate of Lassa fever in children.
  • To identify risk factors associated with mortality in pediatric LFD cases.

Main Methods:

  • Prospective observational study involving 183 pediatric LFD suspects.
  • Lassa virus PCR testing to confirm diagnosis.
  • Structured questionnaires for socio-demographic data collection and clinical symptom assessment.

Main Results:

  • A Lassa virus PCR positivity rate of 13.1% (24 out of 183 children) was observed.
  • The case fatality rate (CFR) for pediatric LFD was high at 29.2% (7 out of 24 children).
  • Convulsions, unconsciousness, bleeding, and poor urine output were significantly associated with increased mortality (p=0.020).

Conclusions:

  • Pediatric Lassa fever disease exhibits high positivity and case fatality rates.
  • Public awareness campaigns on LFD symptoms and early healthcare seeking for febrile children are essential.
  • Urgent medical attention for children presenting with fever, especially with concerning symptoms, is recommended.
Abstract